New pill aims to control advanced tumors in early human test

NCT ID NCT06943677

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tests an experimental oral drug called TQB3019 in 80 adults with advanced malignant tumors that have come back or not responded to treatment. The main goals are to check safety, find the right dose, and get a first look at whether the drug can shrink tumors. Participants take the capsule by mouth, and the study is not yet complete.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANT CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Affiliated Hospital of North sichuan Medical college

    NOT_YET_RECRUITING

    Nanchong, Sichuan, 637000, China

  • Cancer Institute & Hospital.Chinese Academy of Medical Sciences

    NOT_YET_RECRUITING

    Beijing, Beijing Municipality, 100021, China

  • Heze Municipal Hospital

    NOT_YET_RECRUITING

    Heze, Shandong, 27400, China

  • Institute of Hematology &Blood Diseases Hospital,Chinese Academy of Medical Sciences &Peking Union Medical College

    NOT_YET_RECRUITING

    Tianjin, Tianjin Municipality, 301617, China

  • Jiangsu Province Hospital

    NOT_YET_RECRUITING

    Nanjing, Jiangsu, 210029, China

  • Mianyang Central Hospital

    NOT_YET_RECRUITING

    Mianyang, Sichuan, 621000, China

  • Nanfang Hospital of Southern Medical University

    NOT_YET_RECRUITING

    Guangzhou, Guangdong, 510515, China

  • The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital

    RECRUITING

    Zhengzhou, Henan, 450000, China

  • The Affiliated Hospital of Qingdao University

    NOT_YET_RECRUITING

    Qingdao, Shandong, 266075, China

  • The Affiliated Hospital of Southwest Medical University

    NOT_YET_RECRUITING

    Luzhou, Sichuan, 646099, China

  • The Cancer Hospital Affiliated to Shandong First Medical University

    NOT_YET_RECRUITING

    Jinan, Shandong, 250117, China

  • The First Affiliated Hospital of Nanchang University

    NOT_YET_RECRUITING

    Nanchang, Jiangxi, 330006, China

  • The First Affiliated Hospital of Xi'an Jiaotong University

    NOT_YET_RECRUITING

    Xi'an, Shaanxi, 710061, China

  • TianJin Medical University Cancer Institute&Hospital

    NOT_YET_RECRUITING

    Tianjin, Tianjin Municipality, 300000, China

  • Tongji Hospital of Tongji University

    NOT_YET_RECRUITING

    Shanghai, Shanghai Municipality, 200065, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.